Fluorine-18-FPH for PET imaging of nicotinic acetylcholine receptors

Journal of Nuclear Medicine

Volumn 38, Issue 8, 1997, Pages 1260-1265

  Horti, Andrew ^a   Scheffel, Ursula ^a   Stathis, Marigo ^a   Finley, Paige ^a   Ravert, Hayden T ^a   London, Edythe D ^a   Dannais, Robert F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain imaging; Nicotinic acetylcholine receptor; PET

Indexed keywords

2 (2 FLUORO 5 PYRIDYL) 7 AZABICYCLO[2.2.1]HEPTANE; CYSTINE; EPIBATIDINE; FLUORINE 18; LOBELINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; TRACER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING KINETICS; BRAIN; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN; FLUORINE RADIOISOTOPES; MALE; MICE; PYRIDINES; RECEPTORS, NICOTINIC; TIME FACTORS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030824786     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Deneris E, Bouler J, Connolly J, et al. Genes encoding neuronal nicotinic acetylcholine receptors. Clin Chem 1989;35:731-737.
2. Cheney DL. Neuronal nAChRs: molecular biology. Neurosci Facts 1991;2:2-3.
3. McKay J, Lindstrom J, Loring RH. Détermination of nicotinic receptor subtypes in chick retina using monoclonal antibodies and 3H-epibatidine. Med Chem Res 1994;4: 528-537.
4. Boksa P, Quirion R. [3H]N-methylcarbamylcholine: a new radioligand specific for nicotinic acetylcholine receptors in brain. Eur J Pharmacol 1987;139:323-333.
5. London ED, Waller SB, Wamsley JK. Autoradiographic localization of [3H]nicotine binding sites in the rat brain. Neurosci Lett 1985;53:179-184.
6. Perry DC, Kellar K.J. [3H]epibatidine labels nicotinic receptors in rat brain: autoradiographic study. J Pharmacol Exp Ther 1995;285:1030-1034.
7. Broussolle EP, Wong DF, Fanelli RJ, London ED. In vivo specific binding of [3H]l-nicotine in the mouse brain. Life Sei 1989;44:1123-1132.
8. London ED, Connolly RJ, Szikszay M, Wamsley JK, Dam M. Effects of nicotine on local cerebral glucose utilization in the rat. J Neurosci 1988;8:3920-3928.
9. Schröder H, Giacobini E, Wevers A, Birtsch C, Schutz U. Nicotinic receptors in Alzheimer's disease. In: Brain Imaging of nicotine and tobacco smoking. Ann Arbor, MI, NPP Books; 1995:73-93.
10. Court JA, Perry EK. CNS nicotinic receptors: possible therapeutic targets in neurodegenerative disorders. CNS Drugs 1994;2:216-233.
11. Centers for Disease Control and Prevention. Cigarette smoking-attributable mortality and years of potential life lost-United States, 1988. Morb Mortal Wklv Rep 1993;42:37-39.
12. Maziere M, Comar D, Marazano C, Berger G. Nicotine-' 'C: synthesis and distribution kinetics in animals. Eur J Nucl Med 1976; 1:255-258.
13. Nordberg A, Hartvig P, Lundqvist H, et al. Uptake and regional distribution of (+)-(R)- and ( -)-(S)-(N-methyl-"C)-nicotine in the brains of Rhesus monkeys: an attempt to study nicotinic receptors in vivo. J. Neural Transm Parkinson 's Dis Dementia Sect 1989;!: 195-205.
14. Nyback H, Nordberg A, Längström B, et al. Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Prog Brain Res 1989;79:313-319.
15. Whitehouse PJ, Martine AM, Antuono PG, et al. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 1986;371:146-151.
16. London ED, Ball MJ, Waller SB. Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia. Neurochem Res 1989;14:745-750.
17. Fiesher JE, Scheffel U, London ED, Frost JJ. In vivo labeling of nicotinic cholinergic receptors in brain with [3H]cytisine. Life Sei 1994;54:1883-1890.
18. Daly JW, Brown GB, Mensah-Dwumah M, Myers CW. A new class of indolizidine alkaloids from the poison frog, Dendrobates tricolor: x-ray analysis of 8-hydroxy-8methyl-6-(2'-methylhexylidene)-l-azabicyclo[4.3.0]nonane. J Am Chem Soc 1980; 102:830-836.
19. Daly JW, Myers CW, Whittaker N. Further classification of skin alkaloids from neotropical poison frogs (dendobatidae), with a general survey of toxic/noxious substances in the amphibia. Toxicon 1987;25:1023-1095.
20. Spande TF, Garaffo HM, Edwards MW, Yeh HJC, Pannell L, Daly JW. Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadorian poison frog. J Am Chem Soc 1992;! 14:3475-3478.
21. Badio B, Daly JW. Epibatidine, a potent analgetic and nicotinic agonist. Mol Pharmacol 1994;45:563-569.
22. Badio B, Garraffo HM, Spande TF, Daly JW. Epibatidine: discovery and definition as a potent analgesic and nicotinic agonist. Med Chem Res 1994;4:440-448.
23. Qian C, Li T, Shen TY, Libertine-Garahan L, Eckman J, Biftu T, Ip S. Epibatidine is a nicotinic analgesic. Eur J Pharmacol 1993;250:R13-R14.
24. Dukat M, Damaj MI, Glassco W, et al. Epibatidine: a very high affinity nicotinereceptor ligand. Med Chem Res 1993;4:131-139.
25. Bonhaus DW, Bley KR, Broka ÇA, et al. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. J Pharmacol Exp Ther 1995;272: 1199-1203.
26. Sullivan JP, Decker MW, Brioni JD, et al. ( ±)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J Pharmacol Exp Ther 1994;271:624-631.
27. Damaj MI, Creasy KR, Grove AD, Rosecrans JA, Martin BR. Pharmacological effects of epibatidine optical enantiomers. Brain Res 1994;664:34-40.
28. Houghtling RA, Davila-Garcia MI, Kellar KJ. Characterization of (+)-[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 1995;48:280-287.
29. London ED, Scheffel U, Kimes AS, Kellar KJ. In vivo labeling of nicotinic acetylcholine receptors in brain with [3H]epibatidine. Eur J Pharmacol 1995;278:R1R2.
30. Scheffel U, Taylor GF, Kepler JA, Carroll FI, Kuhar Mi. In vivo labeling of neuronal nicotinic acetylcholine receptors with radiolabeled isomers of norchloroepibatidine. NeuroReport 1995;6:2483-2488.
31. Horti AG, Ravert HT, London ED, Dannais RF. Synthesis of a radiotracer for studying nicotinic acetylcholine receptors by positron emission tomography: (±)-exo-2-(2[l8F]fluoro-5-pyridyl)-7-azabicyclo[2.2.1]heptane. J Lab Compd Radiopharm 1996; 38:355-366.
32. Scheffel U, Ricaurte GA. Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand? Brain Res 1990;527:89-95.
33. London ED, Waller SB, Wamsley JK. Autoradiographic localization of [3H]nicotine binding sites in the rat brain. Neurosci Lett 1985;53:179-184.
34. Scheffel U, Pögün S, Stathis M, Boja JW, Kuhar MJ. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428. J Pharmacol Exp Ther 1991;257:954-958.
35. Snyder WS, Ford MR, Warner GG, Watson SB. "S," absorbed dose per unit cumulated activity for selected radionuclides and organs. In: NM/M1RD Pamphlet No.ll. Oak Ridge, TN: Oak Ridge National Laboratory; 1975.
36. Decker MW, Brioni JD, Bannon AW, Arneric SP. Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sei 1995:56:545-570.
37. Bradlow HL, Vanderwerf CA. Studies on the acid hydrolysis of a-halogenated pyridine compounds. J Org Chem 1949;14:509-515.
38. Fisher M, Huangfu D, Shen TY, Guyenet PG. Epibatidine, an alkaloid from the poison frog Epipedobates tricolor, is a powerful ganglionic depolarizing agent. J Pharmacol Exp Ther 1994:270:702-707.
39. Villemagne VL, Horti A, Scheffel U, Ravert HT, Finley P, London ED, Dannais RF. Imaging nicotinic acetylcholine receptors in baboon brain by PET [J. J Nucl Med 1996;37(suppl);37:llP.
40. Ding Y-S, Galley J, Fowler JS, et al. Mapping nicotinic acetylcholine receptors with PET. Synapse 1996:24:403-4407.